Skip to main content
logo
Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
151.28
-0.93 (-0.61%)
At close: Sep 29, 2026, 4:00 PM EDT
151.83
+0.55 (0.36%)
After-hours: Sep 29, 2026, 7:45 PM EDT

Gilead Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Revenue
7,8036,9607,9247,7697,0816,6677,5697,5456,9536,6867,1147,0506,5996,3527,3897,0426,2606,5907,2447,421
Other Revenue
--1-1---1-----------
Revenue
7,8036,9607,9257,7697,0826,6677,5697,5456,9546,6867,1147,0506,5996,3527,3897,0426,2606,5907,2447,421
Revenue Growth (YoY)
10.18%4.40%4.70%2.97%1.84%-0.28%6.40%7.02%5.38%5.26%-3.72%0.11%5.42%-3.61%2.00%-5.11%0.69%2.60%-2.38%12.83%
Cost of Revenue
1,5791,4451,6201,5691,5011,5401,5811,5741,5441,5521,5601,5651,4421,4011,3961,3951,4421,4241,3771,398
Gross Profit
6,2245,5156,3056,2005,5815,1275,9885,9715,4105,1345,5545,4855,1574,9515,9935,6474,8185,1665,8676,023
Selling, General & Admin
1,9061,4261,7771,3521,3581,2221,8611,4101,3691,3621,5801,3151,8491,3192,0201,2131,3571,0831,6501,190
Research & Development
1,6901,3551,5661,3341,4501,3391,6121,3851,3481,4701,4511,4591,3991,4501,5881,1191,1021,1681,3581,101
Operating Expenses
3,5962,7813,3432,6862,8082,5613,4732,7952,7172,8323,0312,7743,2482,7693,6082,3322,4592,2513,0082,291
Operating Income
2,6282,7342,9623,5142,7732,5662,5153,1762,6932,3022,5232,7111,9092,1822,3853,3152,3592,9152,8593,732
Interest Expense
-247-240-255-256-254-260-249-238-237-254-252-232-230-230-226-229-242-238-238-250
Interest & Investment Income
4595958873948552351081021069078376-----
Currency Exchange Gain (Loss)
-16-5022-20-7-38736-54-15-2--42-214519-34-2
Other Non Operating Income (Expenses)
--851-23131145-11-1-4585-44-28342-26-3434-10
EBT Excluding Unusual Items
2,4252,5872,8033,3452,5852,4042,3582,9862,4932,1582,3772,5751,7632,0342,2103,1072,1362,6622,6213,470
Merger & Restructuring Charges
-17-39-37-13-13-74-76-28-21-63-578---------
Gain (Loss) on Sale of Investments
343142253483142-426-126258-392-19189-16869-256-61-197-303-9657-142
Legal Settlements
-------------------1,250175
Other Unusual Items
-72-3-2-4-35-21-510-632-8340-30--10--
Pretax Income
-10,2542,5802,0783,6412,4281,6492,1689562,052-4,4851,6542,3181,5881,3002,0312,4321,503-1527593,438
Income Tax Expense
242559-105589468334385-297438-315237146549316398646368-164383852
Earnings From Continuing Operations
-10,4962,0212,1833,0521,9601,3151,7831,2531,614-4,1701,4172,1721,0399841,6331,7861,135123762,586
Minority Interest in Earnings
----------128626739766
Net Income
-10,4962,0212,1833,0521,9601,3151,7831,2531,614-4,1701,4292,1801,0451,0101,6401,7891,144193822,592
Net Income to Common
-10,4962,0212,1833,0521,9601,3151,7831,2531,614-4,1701,4292,1801,0451,0101,6401,7891,144193822,592
Net Income Growth (YoY)
-53.69%22.43%143.58%21.44%-24.77%-42.52%54.45%--12.87%21.86%-8.65%5215.79%329.32%-30.98%-24.84%-98.90%-75.37%620.00%
Shares Outstanding (Basic)
1,2431,2421,2421,2431,2451,2461,2481,2471,2471,2471,2481,2481,2491,2481,2521,2551,2561,2551,2561,256
Shares Outstanding (Diluted)
1,2431,2541,2531,2541,2551,2591,2591,2541,2511,2471,2561,2571,2581,2611,2641,2611,2601,2621,2621,262
Shares Change (YoY)
-0.96%-0.40%-0.48%-0.32%0.96%0.24%-0.24%-0.56%-1.11%-0.63%-0.32%-0.16%-0.08%0.16%-0.08%--0.24%0.08%
EPS (Basic)
-8.441.631.762.461.571.061.431.001.29-3.341.151.750.840.811.311.430.910.020.302.06
EPS (Diluted)
-8.451.611.742.431.561.041.411.001.29-3.341.131.730.830.801.301.420.910.020.302.05
EPS Growth (YoY)
-54.81%23.41%143.00%20.93%-24.78%-42.20%55.42%--13.13%21.83%-8.79%5184.36%333.26%-30.73%-24.79%-98.89%-75.72%614.65%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
3,4332,4273,1223,9617201,6532,8284,1681,1952,1141,9541,6332,1991,6352,3862,7061,6591,5933,0493,114
Free Cash Flow Per Share
2.761.942.493.160.571.312.253.320.951.701.561.301.751.301.892.151.321.262.422.47
Dividend Per Share
0.8200.8200.7900.7900.7900.7900.7700.7700.7700.7700.7500.7500.7500.7500.7300.7300.7300.7300.7100.710
Dividend Growth (YoY)
3.80%3.80%2.60%2.60%2.60%2.60%2.67%2.67%2.67%2.67%2.74%2.74%2.74%2.74%2.82%2.82%2.82%2.82%4.41%4.41%
Gross Margin
79.76%79.24%79.56%79.80%78.81%76.90%79.11%79.14%77.80%76.79%78.07%77.80%78.15%77.94%81.11%80.19%76.96%78.39%80.99%81.16%
Operating Margin
33.68%39.28%37.38%45.23%39.16%38.49%33.23%42.09%38.73%34.43%35.47%38.45%28.93%34.35%32.28%47.08%37.68%44.23%39.47%50.29%
Profit Margin
-134.51%29.04%27.55%39.28%27.68%19.72%23.56%16.61%23.21%-62.37%20.09%30.92%15.84%15.90%22.20%25.41%18.27%0.29%5.27%34.93%
Free Cash Flow Margin
44.00%34.87%39.39%50.98%10.17%24.79%37.36%55.24%17.18%31.62%27.47%23.16%33.32%25.74%32.29%38.43%26.50%24.17%42.09%41.96%
EBITDA
3,3263,4233,6494,2003,4643,2623,2083,8663,3872,9923,2113,3952,5902,8222,9133,8402,8843,4403,3944,255
EBITDA Margin
42.63%49.18%46.04%54.06%48.91%48.93%42.38%51.24%48.71%44.75%45.14%48.16%39.25%44.43%39.42%54.53%46.07%52.20%46.85%57.34%
D&A For EBITDA
698689687686691696693690694690688684681640528525525525535523
EBIT
2,6282,7342,9623,5142,7732,5662,5153,1762,6932,3022,5232,7111,9092,1822,3853,3152,3592,9152,8593,732
EBIT Margin
33.68%39.28%37.38%45.23%39.16%38.49%33.23%42.09%38.73%34.43%35.47%38.45%28.93%34.35%32.28%47.08%37.68%44.23%39.47%50.29%
Effective Tax Rate
-21.67%-16.18%19.28%20.26%17.76%-21.34%-14.33%6.30%34.57%24.31%19.60%26.56%24.48%-50.46%24.78%
Revenue as Reported
7,8036,9607,9257,7697,0826,6677,5697,5456,9546,6867,1147,0516,5996,3527,3897,0426,2606,5907,2447,421
SEC Filings: 10-K · 10-Q